nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCB1—esophageal cancer	0.293	1	CbGaD
Venlafaxine—ABCG2—Carboplatin—esophageal cancer	0.0904	0.224	CbGbCtD
Venlafaxine—ABCG2—Cisplatin—esophageal cancer	0.0773	0.191	CbGbCtD
Venlafaxine—CYP2C9—Capecitabine—esophageal cancer	0.057	0.141	CbGbCtD
Venlafaxine—CYP2B6—Cisplatin—esophageal cancer	0.0544	0.135	CbGbCtD
Venlafaxine—ABCG2—Methotrexate—esophageal cancer	0.0502	0.124	CbGbCtD
Venlafaxine—CYP2C9—Cisplatin—esophageal cancer	0.0287	0.0711	CbGbCtD
Venlafaxine—ABCB1—Cisplatin—esophageal cancer	0.0279	0.069	CbGbCtD
Venlafaxine—ABCB1—Methotrexate—esophageal cancer	0.0181	0.0448	CbGbCtD
Venlafaxine—Aplastic anaemia—Methotrexate—esophageal cancer	0.000324	0.00181	CcSEcCtD
Venlafaxine—Bradycardia—Cisplatin—esophageal cancer	0.000322	0.0018	CcSEcCtD
Venlafaxine—Irritability—Capecitabine—esophageal cancer	0.000321	0.0018	CcSEcCtD
Venlafaxine—Urinary retention—Capecitabine—esophageal cancer	0.00032	0.00179	CcSEcCtD
Venlafaxine—Cardiac arrest—Capecitabine—esophageal cancer	0.00032	0.00179	CcSEcCtD
Venlafaxine—Mood swings—Capecitabine—esophageal cancer	0.000319	0.00178	CcSEcCtD
Venlafaxine—Ataxia—Capecitabine—esophageal cancer	0.000317	0.00177	CcSEcCtD
Venlafaxine—Blood creatinine increased—Capecitabine—esophageal cancer	0.000315	0.00176	CcSEcCtD
Venlafaxine—Dehydration—Capecitabine—esophageal cancer	0.000313	0.00175	CcSEcCtD
Venlafaxine—Urine output increased—Methotrexate—esophageal cancer	0.000312	0.00175	CcSEcCtD
Venlafaxine—Mouth ulceration—Methotrexate—esophageal cancer	0.000312	0.00175	CcSEcCtD
Venlafaxine—Bladder pain—Methotrexate—esophageal cancer	0.000312	0.00175	CcSEcCtD
Venlafaxine—Ecchymosis—Methotrexate—esophageal cancer	0.000312	0.00175	CcSEcCtD
Venlafaxine—Liver function test abnormal—Capecitabine—esophageal cancer	0.000311	0.00174	CcSEcCtD
Venlafaxine—Gynaecomastia—Methotrexate—esophageal cancer	0.000309	0.00173	CcSEcCtD
Venlafaxine—Dry skin—Capecitabine—esophageal cancer	0.000309	0.00173	CcSEcCtD
Venlafaxine—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000307	0.00172	CcSEcCtD
Venlafaxine—Hypokalaemia—Capecitabine—esophageal cancer	0.000306	0.00171	CcSEcCtD
Venlafaxine—Visual impairment—Cisplatin—esophageal cancer	0.000304	0.0017	CcSEcCtD
Venlafaxine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000303	0.00169	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000303	0.00169	CcSEcCtD
Venlafaxine—Gastritis—Capecitabine—esophageal cancer	0.000298	0.00167	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000297	0.00166	CcSEcCtD
Venlafaxine—Muscular weakness—Capecitabine—esophageal cancer	0.000297	0.00166	CcSEcCtD
Venlafaxine—Tinnitus—Cisplatin—esophageal cancer	0.000295	0.00165	CcSEcCtD
Venlafaxine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000294	0.00164	CcSEcCtD
Venlafaxine—Flushing—Cisplatin—esophageal cancer	0.000293	0.00164	CcSEcCtD
Venlafaxine—Cardiac disorder—Cisplatin—esophageal cancer	0.000293	0.00164	CcSEcCtD
Venlafaxine—Abdominal distension—Capecitabine—esophageal cancer	0.000293	0.00164	CcSEcCtD
Venlafaxine—Asthma—Capecitabine—esophageal cancer	0.000291	0.00163	CcSEcCtD
Venlafaxine—Influenza—Capecitabine—esophageal cancer	0.000291	0.00163	CcSEcCtD
Venlafaxine—Dysphagia—Capecitabine—esophageal cancer	0.000291	0.00163	CcSEcCtD
Venlafaxine—Thrombophlebitis—Methotrexate—esophageal cancer	0.00029	0.00162	CcSEcCtD
Venlafaxine—Diabetes mellitus—Methotrexate—esophageal cancer	0.000288	0.00161	CcSEcCtD
Venlafaxine—Polyuria—Methotrexate—esophageal cancer	0.000285	0.0016	CcSEcCtD
Venlafaxine—Angina pectoris—Capecitabine—esophageal cancer	0.000283	0.00158	CcSEcCtD
Venlafaxine—Arrhythmia—Cisplatin—esophageal cancer	0.000282	0.00158	CcSEcCtD
Venlafaxine—Bronchitis—Capecitabine—esophageal cancer	0.00028	0.00156	CcSEcCtD
Venlafaxine—Alopecia—Cisplatin—esophageal cancer	0.000279	0.00156	CcSEcCtD
Venlafaxine—Pancytopenia—Capecitabine—esophageal cancer	0.000276	0.00154	CcSEcCtD
Venlafaxine—Erythema—Cisplatin—esophageal cancer	0.000275	0.00154	CcSEcCtD
Venlafaxine—Neutropenia—Capecitabine—esophageal cancer	0.000272	0.00152	CcSEcCtD
Venlafaxine—Dysuria—Capecitabine—esophageal cancer	0.000272	0.00152	CcSEcCtD
Venlafaxine—Flatulence—Cisplatin—esophageal cancer	0.000271	0.00152	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00027	0.00151	CcSEcCtD
Venlafaxine—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000266	0.00148	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000266	0.00148	CcSEcCtD
Venlafaxine—Weight increased—Capecitabine—esophageal cancer	0.000265	0.00148	CcSEcCtD
Venlafaxine—Visual disturbance—Methotrexate—esophageal cancer	0.000264	0.00148	CcSEcCtD
Venlafaxine—Muscle spasms—Cisplatin—esophageal cancer	0.000264	0.00148	CcSEcCtD
Venlafaxine—Weight decreased—Capecitabine—esophageal cancer	0.000263	0.00147	CcSEcCtD
Venlafaxine—Hyperglycaemia—Capecitabine—esophageal cancer	0.000262	0.00147	CcSEcCtD
Venlafaxine—Pneumonia—Capecitabine—esophageal cancer	0.000261	0.00146	CcSEcCtD
Venlafaxine—Vision blurred—Cisplatin—esophageal cancer	0.000259	0.00145	CcSEcCtD
Venlafaxine—Depression—Capecitabine—esophageal cancer	0.000259	0.00145	CcSEcCtD
Venlafaxine—Tremor—Cisplatin—esophageal cancer	0.000258	0.00144	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000257	0.00144	CcSEcCtD
Venlafaxine—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000256	0.00143	CcSEcCtD
Venlafaxine—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000256	0.00143	CcSEcCtD
Venlafaxine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000255	0.00143	CcSEcCtD
Venlafaxine—Renal failure—Capecitabine—esophageal cancer	0.000255	0.00143	CcSEcCtD
Venlafaxine—Myocardial infarction—Capecitabine—esophageal cancer	0.000254	0.00142	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000254	0.00142	CcSEcCtD
Venlafaxine—Anaemia—Cisplatin—esophageal cancer	0.000254	0.00142	CcSEcCtD
Venlafaxine—Stomatitis—Capecitabine—esophageal cancer	0.000253	0.00141	CcSEcCtD
Venlafaxine—Jaundice—Capecitabine—esophageal cancer	0.000253	0.00141	CcSEcCtD
Venlafaxine—Conjunctivitis—Capecitabine—esophageal cancer	0.000252	0.00141	CcSEcCtD
Venlafaxine—Osteoarthritis—Methotrexate—esophageal cancer	0.000251	0.0014	CcSEcCtD
Venlafaxine—Malaise—Cisplatin—esophageal cancer	0.000248	0.00139	CcSEcCtD
Venlafaxine—Haematuria—Capecitabine—esophageal cancer	0.000247	0.00138	CcSEcCtD
Venlafaxine—Leukopenia—Cisplatin—esophageal cancer	0.000246	0.00138	CcSEcCtD
Venlafaxine—Epistaxis—Capecitabine—esophageal cancer	0.000245	0.00137	CcSEcCtD
Venlafaxine—Agranulocytosis—Capecitabine—esophageal cancer	0.000242	0.00135	CcSEcCtD
Venlafaxine—Irritability—Methotrexate—esophageal cancer	0.000239	0.00134	CcSEcCtD
Venlafaxine—Convulsion—Cisplatin—esophageal cancer	0.000238	0.00133	CcSEcCtD
Venlafaxine—Mood swings—Methotrexate—esophageal cancer	0.000237	0.00133	CcSEcCtD
Venlafaxine—Bradycardia—Capecitabine—esophageal cancer	0.000237	0.00133	CcSEcCtD
Venlafaxine—Ataxia—Methotrexate—esophageal cancer	0.000236	0.00132	CcSEcCtD
Venlafaxine—Myalgia—Cisplatin—esophageal cancer	0.000234	0.00131	CcSEcCtD
Venlafaxine—Haemoglobin—Capecitabine—esophageal cancer	0.000234	0.00131	CcSEcCtD
Venlafaxine—Rhinitis—Capecitabine—esophageal cancer	0.000233	0.00131	CcSEcCtD
Venlafaxine—Anxiety—Cisplatin—esophageal cancer	0.000233	0.0013	CcSEcCtD
Venlafaxine—Hepatitis—Capecitabine—esophageal cancer	0.000233	0.0013	CcSEcCtD
Venlafaxine—Haemorrhage—Capecitabine—esophageal cancer	0.000233	0.0013	CcSEcCtD
Venlafaxine—Hypoaesthesia—Capecitabine—esophageal cancer	0.000232	0.0013	CcSEcCtD
Venlafaxine—Liver function test abnormal—Methotrexate—esophageal cancer	0.000231	0.00129	CcSEcCtD
Venlafaxine—Discomfort—Cisplatin—esophageal cancer	0.000231	0.00129	CcSEcCtD
Venlafaxine—Pharyngitis—Capecitabine—esophageal cancer	0.000231	0.00129	CcSEcCtD
Venlafaxine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000226	0.00126	CcSEcCtD
Venlafaxine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000224	0.00125	CcSEcCtD
Venlafaxine—Oedema—Cisplatin—esophageal cancer	0.000224	0.00125	CcSEcCtD
Venlafaxine—Visual impairment—Capecitabine—esophageal cancer	0.000224	0.00125	CcSEcCtD
Venlafaxine—Infection—Cisplatin—esophageal cancer	0.000223	0.00125	CcSEcCtD
Venlafaxine—Erythema multiforme—Capecitabine—esophageal cancer	0.00022	0.00123	CcSEcCtD
Venlafaxine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00022	0.00123	CcSEcCtD
Venlafaxine—Tachycardia—Cisplatin—esophageal cancer	0.000219	0.00122	CcSEcCtD
Venlafaxine—Tinnitus—Capecitabine—esophageal cancer	0.000217	0.00121	CcSEcCtD
Venlafaxine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000217	0.00121	CcSEcCtD
Venlafaxine—Asthma—Methotrexate—esophageal cancer	0.000217	0.00121	CcSEcCtD
Venlafaxine—Cardiac disorder—Capecitabine—esophageal cancer	0.000216	0.00121	CcSEcCtD
Venlafaxine—Flushing—Capecitabine—esophageal cancer	0.000216	0.00121	CcSEcCtD
Venlafaxine—Eosinophilia—Methotrexate—esophageal cancer	0.000214	0.0012	CcSEcCtD
Venlafaxine—Anorexia—Cisplatin—esophageal cancer	0.000214	0.0012	CcSEcCtD
Venlafaxine—Pancreatitis—Methotrexate—esophageal cancer	0.000212	0.00119	CcSEcCtD
Venlafaxine—Hypotension—Cisplatin—esophageal cancer	0.00021	0.00117	CcSEcCtD
Venlafaxine—Chills—Capecitabine—esophageal cancer	0.000209	0.00117	CcSEcCtD
Venlafaxine—Arrhythmia—Capecitabine—esophageal cancer	0.000208	0.00116	CcSEcCtD
Venlafaxine—Alopecia—Capecitabine—esophageal cancer	0.000206	0.00115	CcSEcCtD
Venlafaxine—Pancytopenia—Methotrexate—esophageal cancer	0.000206	0.00115	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000205	0.00114	CcSEcCtD
Venlafaxine—Erythema—Capecitabine—esophageal cancer	0.000203	0.00113	CcSEcCtD
Venlafaxine—Neutropenia—Methotrexate—esophageal cancer	0.000203	0.00113	CcSEcCtD
Venlafaxine—Dysuria—Methotrexate—esophageal cancer	0.000203	0.00113	CcSEcCtD
Venlafaxine—Paraesthesia—Cisplatin—esophageal cancer	0.000202	0.00113	CcSEcCtD
Venlafaxine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000201	0.00113	CcSEcCtD
Venlafaxine—Dyspnoea—Cisplatin—esophageal cancer	0.0002	0.00112	CcSEcCtD
Venlafaxine—Flatulence—Capecitabine—esophageal cancer	0.0002	0.00112	CcSEcCtD
Venlafaxine—Erectile dysfunction—Methotrexate—esophageal cancer	0.000199	0.00112	CcSEcCtD
Venlafaxine—Dysgeusia—Capecitabine—esophageal cancer	0.000199	0.00111	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000198	0.00111	CcSEcCtD
Venlafaxine—Back pain—Capecitabine—esophageal cancer	0.000196	0.0011	CcSEcCtD
Venlafaxine—Decreased appetite—Cisplatin—esophageal cancer	0.000195	0.00109	CcSEcCtD
Venlafaxine—Muscle spasms—Capecitabine—esophageal cancer	0.000195	0.00109	CcSEcCtD
Venlafaxine—Pneumonia—Methotrexate—esophageal cancer	0.000194	0.00109	CcSEcCtD
Venlafaxine—Depression—Methotrexate—esophageal cancer	0.000193	0.00108	CcSEcCtD
Venlafaxine—Pain—Cisplatin—esophageal cancer	0.000192	0.00107	CcSEcCtD
Venlafaxine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000191	0.00107	CcSEcCtD
Venlafaxine—Vision blurred—Capecitabine—esophageal cancer	0.000191	0.00107	CcSEcCtD
Venlafaxine—Tremor—Capecitabine—esophageal cancer	0.00019	0.00106	CcSEcCtD
Venlafaxine—Renal failure—Methotrexate—esophageal cancer	0.00019	0.00106	CcSEcCtD
Venlafaxine—Stomatitis—Methotrexate—esophageal cancer	0.000188	0.00105	CcSEcCtD
Venlafaxine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000188	0.00105	CcSEcCtD
Venlafaxine—Conjunctivitis—Methotrexate—esophageal cancer	0.000188	0.00105	CcSEcCtD
Venlafaxine—Anaemia—Capecitabine—esophageal cancer	0.000187	0.00105	CcSEcCtD
Venlafaxine—Sweating—Methotrexate—esophageal cancer	0.000185	0.00104	CcSEcCtD
Venlafaxine—Feeling abnormal—Cisplatin—esophageal cancer	0.000185	0.00103	CcSEcCtD
Venlafaxine—Haematuria—Methotrexate—esophageal cancer	0.000184	0.00103	CcSEcCtD
Venlafaxine—Malaise—Capecitabine—esophageal cancer	0.000183	0.00102	CcSEcCtD
Venlafaxine—Epistaxis—Methotrexate—esophageal cancer	0.000182	0.00102	CcSEcCtD
Venlafaxine—Vertigo—Capecitabine—esophageal cancer	0.000182	0.00102	CcSEcCtD
Venlafaxine—Syncope—Capecitabine—esophageal cancer	0.000182	0.00102	CcSEcCtD
Venlafaxine—Leukopenia—Capecitabine—esophageal cancer	0.000181	0.00101	CcSEcCtD
Venlafaxine—Agranulocytosis—Methotrexate—esophageal cancer	0.00018	0.00101	CcSEcCtD
Venlafaxine—Palpitations—Capecitabine—esophageal cancer	0.000179	0.001	CcSEcCtD
Venlafaxine—Loss of consciousness—Capecitabine—esophageal cancer	0.000178	0.000996	CcSEcCtD
Venlafaxine—Body temperature increased—Cisplatin—esophageal cancer	0.000177	0.000992	CcSEcCtD
Venlafaxine—Cough—Capecitabine—esophageal cancer	0.000177	0.000989	CcSEcCtD
Venlafaxine—Hypertension—Capecitabine—esophageal cancer	0.000175	0.000979	CcSEcCtD
Venlafaxine—Haemoglobin—Methotrexate—esophageal cancer	0.000174	0.000974	CcSEcCtD
Venlafaxine—Hepatitis—Methotrexate—esophageal cancer	0.000173	0.000969	CcSEcCtD
Venlafaxine—Haemorrhage—Methotrexate—esophageal cancer	0.000173	0.000969	CcSEcCtD
Venlafaxine—Arthralgia—Capecitabine—esophageal cancer	0.000173	0.000965	CcSEcCtD
Venlafaxine—Chest pain—Capecitabine—esophageal cancer	0.000173	0.000965	CcSEcCtD
Venlafaxine—Myalgia—Capecitabine—esophageal cancer	0.000173	0.000965	CcSEcCtD
Venlafaxine—Pharyngitis—Methotrexate—esophageal cancer	0.000172	0.000962	CcSEcCtD
Venlafaxine—Anxiety—Capecitabine—esophageal cancer	0.000172	0.000962	CcSEcCtD
Venlafaxine—Discomfort—Capecitabine—esophageal cancer	0.000171	0.000953	CcSEcCtD
Venlafaxine—Dry mouth—Capecitabine—esophageal cancer	0.000169	0.000944	CcSEcCtD
Venlafaxine—Visual impairment—Methotrexate—esophageal cancer	0.000167	0.000934	CcSEcCtD
Venlafaxine—Confusional state—Capecitabine—esophageal cancer	0.000167	0.000933	CcSEcCtD
Venlafaxine—Oedema—Capecitabine—esophageal cancer	0.000165	0.000925	CcSEcCtD
Venlafaxine—Hypersensitivity—Cisplatin—esophageal cancer	0.000165	0.000925	CcSEcCtD
Venlafaxine—Infection—Capecitabine—esophageal cancer	0.000164	0.000919	CcSEcCtD
Venlafaxine—Erythema multiforme—Methotrexate—esophageal cancer	0.000164	0.000916	CcSEcCtD
Venlafaxine—Shock—Capecitabine—esophageal cancer	0.000163	0.00091	CcSEcCtD
Venlafaxine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000162	0.000906	CcSEcCtD
Venlafaxine—Tinnitus—Methotrexate—esophageal cancer	0.000162	0.000904	CcSEcCtD
Venlafaxine—Tachycardia—Capecitabine—esophageal cancer	0.000161	0.000903	CcSEcCtD
Venlafaxine—Asthenia—Cisplatin—esophageal cancer	0.000161	0.0009	CcSEcCtD
Venlafaxine—Cardiac disorder—Methotrexate—esophageal cancer	0.000161	0.0009	CcSEcCtD
Venlafaxine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00016	0.000894	CcSEcCtD
Venlafaxine—Anorexia—Capecitabine—esophageal cancer	0.000158	0.000882	CcSEcCtD
Venlafaxine—Chills—Methotrexate—esophageal cancer	0.000156	0.00087	CcSEcCtD
Venlafaxine—Hypotension—Capecitabine—esophageal cancer	0.000155	0.000864	CcSEcCtD
Venlafaxine—Diarrhoea—Cisplatin—esophageal cancer	0.000154	0.000859	CcSEcCtD
Venlafaxine—Alopecia—Methotrexate—esophageal cancer	0.000153	0.000857	CcSEcCtD
Venlafaxine—Erythema—Methotrexate—esophageal cancer	0.000151	0.000844	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000151	0.000843	CcSEcCtD
Venlafaxine—Insomnia—Capecitabine—esophageal cancer	0.00015	0.000837	CcSEcCtD
Venlafaxine—Paraesthesia—Capecitabine—esophageal cancer	0.000149	0.000831	CcSEcCtD
Venlafaxine—Dysgeusia—Methotrexate—esophageal cancer	0.000148	0.000826	CcSEcCtD
Venlafaxine—Dyspnoea—Capecitabine—esophageal cancer	0.000148	0.000825	CcSEcCtD
Venlafaxine—Back pain—Methotrexate—esophageal cancer	0.000146	0.000816	CcSEcCtD
Venlafaxine—Dyspepsia—Capecitabine—esophageal cancer	0.000146	0.000814	CcSEcCtD
Venlafaxine—Decreased appetite—Capecitabine—esophageal cancer	0.000144	0.000804	CcSEcCtD
Venlafaxine—Vomiting—Cisplatin—esophageal cancer	0.000143	0.000798	CcSEcCtD
Venlafaxine—Fatigue—Capecitabine—esophageal cancer	0.000143	0.000798	CcSEcCtD
Venlafaxine—Vision blurred—Methotrexate—esophageal cancer	0.000142	0.000795	CcSEcCtD
Venlafaxine—Rash—Cisplatin—esophageal cancer	0.000142	0.000791	CcSEcCtD
Venlafaxine—Constipation—Capecitabine—esophageal cancer	0.000141	0.000791	CcSEcCtD
Venlafaxine—Pain—Capecitabine—esophageal cancer	0.000141	0.000791	CcSEcCtD
Venlafaxine—Dermatitis—Cisplatin—esophageal cancer	0.000141	0.000791	CcSEcCtD
Venlafaxine—Ill-defined disorder—Methotrexate—esophageal cancer	0.00014	0.000783	CcSEcCtD
Venlafaxine—Anaemia—Methotrexate—esophageal cancer	0.000139	0.00078	CcSEcCtD
Venlafaxine—Feeling abnormal—Capecitabine—esophageal cancer	0.000136	0.000762	CcSEcCtD
Venlafaxine—Malaise—Methotrexate—esophageal cancer	0.000136	0.000761	CcSEcCtD
Venlafaxine—Vertigo—Methotrexate—esophageal cancer	0.000136	0.000758	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000135	0.000756	CcSEcCtD
Venlafaxine—Leukopenia—Methotrexate—esophageal cancer	0.000135	0.000755	CcSEcCtD
Venlafaxine—Nausea—Cisplatin—esophageal cancer	0.000133	0.000745	CcSEcCtD
Venlafaxine—Cough—Methotrexate—esophageal cancer	0.000132	0.000736	CcSEcCtD
Venlafaxine—Urticaria—Capecitabine—esophageal cancer	0.000131	0.000735	CcSEcCtD
Venlafaxine—Abdominal pain—Capecitabine—esophageal cancer	0.000131	0.000731	CcSEcCtD
Venlafaxine—Body temperature increased—Capecitabine—esophageal cancer	0.000131	0.000731	CcSEcCtD
Venlafaxine—Convulsion—Methotrexate—esophageal cancer	0.000131	0.000731	CcSEcCtD
Venlafaxine—Arthralgia—Methotrexate—esophageal cancer	0.000128	0.000718	CcSEcCtD
Venlafaxine—Chest pain—Methotrexate—esophageal cancer	0.000128	0.000718	CcSEcCtD
Venlafaxine—Myalgia—Methotrexate—esophageal cancer	0.000128	0.000718	CcSEcCtD
Venlafaxine—Discomfort—Methotrexate—esophageal cancer	0.000127	0.00071	CcSEcCtD
Venlafaxine—Confusional state—Methotrexate—esophageal cancer	0.000124	0.000694	CcSEcCtD
Venlafaxine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000123	0.000689	CcSEcCtD
Venlafaxine—Infection—Methotrexate—esophageal cancer	0.000122	0.000684	CcSEcCtD
Venlafaxine—Hypersensitivity—Capecitabine—esophageal cancer	0.000122	0.000682	CcSEcCtD
Venlafaxine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000121	0.000674	CcSEcCtD
Venlafaxine—Hyperhidrosis—Methotrexate—esophageal cancer	0.000119	0.000666	CcSEcCtD
Venlafaxine—Asthenia—Capecitabine—esophageal cancer	0.000119	0.000664	CcSEcCtD
Venlafaxine—Anorexia—Methotrexate—esophageal cancer	0.000117	0.000656	CcSEcCtD
Venlafaxine—Pruritus—Capecitabine—esophageal cancer	0.000117	0.000654	CcSEcCtD
Venlafaxine—Hypotension—Methotrexate—esophageal cancer	0.000115	0.000643	CcSEcCtD
Venlafaxine—Diarrhoea—Capecitabine—esophageal cancer	0.000113	0.000633	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000112	0.000627	CcSEcCtD
Venlafaxine—Insomnia—Methotrexate—esophageal cancer	0.000111	0.000623	CcSEcCtD
Venlafaxine—Paraesthesia—Methotrexate—esophageal cancer	0.000111	0.000618	CcSEcCtD
Venlafaxine—Dyspnoea—Methotrexate—esophageal cancer	0.00011	0.000614	CcSEcCtD
Venlafaxine—Somnolence—Methotrexate—esophageal cancer	0.00011	0.000612	CcSEcCtD
Venlafaxine—Dizziness—Capecitabine—esophageal cancer	0.000109	0.000612	CcSEcCtD
Venlafaxine—Dyspepsia—Methotrexate—esophageal cancer	0.000108	0.000606	CcSEcCtD
Venlafaxine—Decreased appetite—Methotrexate—esophageal cancer	0.000107	0.000599	CcSEcCtD
Venlafaxine—Fatigue—Methotrexate—esophageal cancer	0.000106	0.000594	CcSEcCtD
Venlafaxine—Pain—Methotrexate—esophageal cancer	0.000105	0.000589	CcSEcCtD
Venlafaxine—Vomiting—Capecitabine—esophageal cancer	0.000105	0.000588	CcSEcCtD
Venlafaxine—Rash—Capecitabine—esophageal cancer	0.000104	0.000583	CcSEcCtD
Venlafaxine—Dermatitis—Capecitabine—esophageal cancer	0.000104	0.000583	CcSEcCtD
Venlafaxine—Headache—Capecitabine—esophageal cancer	0.000104	0.00058	CcSEcCtD
Venlafaxine—Feeling abnormal—Methotrexate—esophageal cancer	0.000102	0.000567	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000101	0.000563	CcSEcCtD
Venlafaxine—Nausea—Capecitabine—esophageal cancer	9.83e-05	0.000549	CcSEcCtD
Venlafaxine—Urticaria—Methotrexate—esophageal cancer	9.79e-05	0.000547	CcSEcCtD
Venlafaxine—Abdominal pain—Methotrexate—esophageal cancer	9.74e-05	0.000544	CcSEcCtD
Venlafaxine—Body temperature increased—Methotrexate—esophageal cancer	9.74e-05	0.000544	CcSEcCtD
Venlafaxine—Hypersensitivity—Methotrexate—esophageal cancer	9.08e-05	0.000507	CcSEcCtD
Venlafaxine—Asthenia—Methotrexate—esophageal cancer	8.84e-05	0.000494	CcSEcCtD
Venlafaxine—Pruritus—Methotrexate—esophageal cancer	8.71e-05	0.000487	CcSEcCtD
Venlafaxine—Diarrhoea—Methotrexate—esophageal cancer	8.43e-05	0.000471	CcSEcCtD
Venlafaxine—Dizziness—Methotrexate—esophageal cancer	8.15e-05	0.000455	CcSEcCtD
Venlafaxine—Vomiting—Methotrexate—esophageal cancer	7.83e-05	0.000438	CcSEcCtD
Venlafaxine—Rash—Methotrexate—esophageal cancer	7.77e-05	0.000434	CcSEcCtD
Venlafaxine—Dermatitis—Methotrexate—esophageal cancer	7.76e-05	0.000434	CcSEcCtD
Venlafaxine—Headache—Methotrexate—esophageal cancer	7.72e-05	0.000431	CcSEcCtD
Venlafaxine—Nausea—Methotrexate—esophageal cancer	7.32e-05	0.000409	CcSEcCtD
Venlafaxine—ABCB1—Metabolism—SLC52A3—esophageal cancer	3.62e-05	0.000292	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—BLVRB—esophageal cancer	3.62e-05	0.000292	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—PIK3CA—esophageal cancer	3.56e-05	0.000288	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ADH7—esophageal cancer	3.54e-05	0.000286	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PLCE1—esophageal cancer	3.54e-05	0.000286	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ALDOB—esophageal cancer	3.51e-05	0.000284	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—BLVRB—esophageal cancer	3.41e-05	0.000275	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC52A3—esophageal cancer	3.41e-05	0.000275	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—NOS3—esophageal cancer	3.4e-05	0.000274	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GAPDH—esophageal cancer	3.38e-05	0.000273	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—BLVRB—esophageal cancer	3.38e-05	0.000273	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC52A3—esophageal cancer	3.38e-05	0.000273	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CRABP1—esophageal cancer	3.35e-05	0.000271	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.31e-05	0.000267	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.27e-05	0.000264	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PIK3CA—esophageal cancer	3.24e-05	0.000261	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GNG7—esophageal cancer	3.19e-05	0.000257	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ERBB2—esophageal cancer	3.18e-05	0.000257	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	3.15e-05	0.000254	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CA1—esophageal cancer	3.15e-05	0.000254	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.12e-05	0.000252	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ADH1B—esophageal cancer	3.11e-05	0.000251	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CA1—esophageal cancer	3.07e-05	0.000248	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.07e-05	0.000248	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.03e-05	0.000245	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.02e-05	0.000244	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ALDH2—esophageal cancer	2.99e-05	0.000241	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TYMP—esophageal cancer	2.97e-05	0.00024	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.97e-05	0.00024	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CA1—esophageal cancer	2.9e-05	0.000234	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SLC10A2—esophageal cancer	2.9e-05	0.000234	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.89e-05	0.000234	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP26A1—esophageal cancer	2.89e-05	0.000233	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CA2—esophageal cancer	2.88e-05	0.000233	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CA1—esophageal cancer	2.87e-05	0.000232	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SLC10A2—esophageal cancer	2.87e-05	0.000232	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTT1—esophageal cancer	2.84e-05	0.000229	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.82e-05	0.000227	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALOX15—esophageal cancer	2.82e-05	0.000227	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CA2—esophageal cancer	2.81e-05	0.000227	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP2A6—esophageal cancer	2.81e-05	0.000227	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CCND1—esophageal cancer	2.81e-05	0.000227	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CDKN1A—esophageal cancer	2.72e-05	0.000219	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTO1—esophageal cancer	2.69e-05	0.000217	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TPI1—esophageal cancer	2.69e-05	0.000217	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.68e-05	0.000216	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PLCE1—esophageal cancer	2.68e-05	0.000216	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ADH7—esophageal cancer	2.68e-05	0.000216	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ENO1—esophageal cancer	2.66e-05	0.000215	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS1—esophageal cancer	2.66e-05	0.000215	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.66e-05	0.000215	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CA2—esophageal cancer	2.65e-05	0.000214	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.65e-05	0.000214	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CA2—esophageal cancer	2.63e-05	0.000212	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PSME1—esophageal cancer	2.62e-05	0.000212	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PSME2—esophageal cancer	2.62e-05	0.000212	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PLCE1—esophageal cancer	2.61e-05	0.000211	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ADH7—esophageal cancer	2.61e-05	0.000211	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.59e-05	0.000209	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EP300—esophageal cancer	2.58e-05	0.000209	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALDOB—esophageal cancer	2.57e-05	0.000208	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.57e-05	0.000207	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GAPDH—esophageal cancer	2.48e-05	0.0002	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.47e-05	0.000199	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PLCE1—esophageal cancer	2.46e-05	0.000199	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ADH7—esophageal cancer	2.46e-05	0.000199	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CRABP1—esophageal cancer	2.46e-05	0.000198	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ADH7—esophageal cancer	2.44e-05	0.000197	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.44e-05	0.000197	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.41e-05	0.000195	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ADH1B—esophageal cancer	2.35e-05	0.00019	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GNG7—esophageal cancer	2.34e-05	0.000189	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ADH1B—esophageal cancer	2.29e-05	0.000185	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP1B1—esophageal cancer	2.26e-05	0.000183	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MYC—esophageal cancer	2.25e-05	0.000182	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TYMP—esophageal cancer	2.24e-05	0.000181	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.24e-05	0.000181	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.23e-05	0.00018	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.23e-05	0.00018	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—EGFR—esophageal cancer	2.2e-05	0.000178	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TYMP—esophageal cancer	2.19e-05	0.000177	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ALDH2—esophageal cancer	2.19e-05	0.000177	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.18e-05	0.000176	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.16e-05	0.000174	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.15e-05	0.000174	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.14e-05	0.000173	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.13e-05	0.000172	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CYP19A1—esophageal cancer	2.13e-05	0.000172	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.13e-05	0.000172	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.1e-05	0.00017	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTT1—esophageal cancer	2.08e-05	0.000168	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALOX15—esophageal cancer	2.08e-05	0.000168	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TYMP—esophageal cancer	2.06e-05	0.000167	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP2A6—esophageal cancer	2.06e-05	0.000166	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TYMP—esophageal cancer	2.05e-05	0.000165	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TPI1—esophageal cancer	2.03e-05	0.000164	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTO1—esophageal cancer	2.03e-05	0.000164	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.01e-05	0.000162	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.99e-05	0.000161	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTO1—esophageal cancer	1.98e-05	0.00016	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TPI1—esophageal cancer	1.98e-05	0.00016	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.96e-05	0.000158	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.95e-05	0.000158	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ENO1—esophageal cancer	1.95e-05	0.000158	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.95e-05	0.000157	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—HMOX1—esophageal cancer	1.94e-05	0.000157	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.94e-05	0.000157	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PSME1—esophageal cancer	1.92e-05	0.000155	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PSME2—esophageal cancer	1.92e-05	0.000155	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PIK3CA—esophageal cancer	1.91e-05	0.000154	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALDOB—esophageal cancer	1.9e-05	0.000153	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.89e-05	0.000153	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CA1—esophageal cancer	1.89e-05	0.000153	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.87e-05	0.000151	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.87e-05	0.000151	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TPI1—esophageal cancer	1.87e-05	0.000151	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—ABCB1—esophageal cancer	1.86e-05	0.000151	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.86e-05	0.00015	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TPI1—esophageal cancer	1.85e-05	0.000149	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.85e-05	0.000149	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—esophageal cancer	1.85e-05	0.000149	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GAPDH—esophageal cancer	1.83e-05	0.000148	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.82e-05	0.000147	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CRABP1—esophageal cancer	1.81e-05	0.000146	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.79e-05	0.000145	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.77e-05	0.000143	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GNG7—esophageal cancer	1.77e-05	0.000143	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.77e-05	0.000143	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CA2—esophageal cancer	1.73e-05	0.00014	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GNG7—esophageal cancer	1.72e-05	0.000139	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.72e-05	0.000139	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.71e-05	0.000138	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.71e-05	0.000138	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.69e-05	0.000137	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.66e-05	0.000134	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.65e-05	0.000134	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GNG7—esophageal cancer	1.62e-05	0.000131	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ALDH2—esophageal cancer	1.61e-05	0.00013	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.61e-05	0.00013	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ADH7—esophageal cancer	1.61e-05	0.00013	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GNG7—esophageal cancer	1.61e-05	0.00013	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.57e-05	0.000127	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.56e-05	0.000126	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.56e-05	0.000126	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.55e-05	0.000125	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTT1—esophageal cancer	1.54e-05	0.000124	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.52e-05	0.000123	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.52e-05	0.000123	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.51e-05	0.000122	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ENO1—esophageal cancer	1.47e-05	0.000119	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.47e-05	0.000119	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PSME2—esophageal cancer	1.45e-05	0.000117	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PSME1—esophageal cancer	1.45e-05	0.000117	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.45e-05	0.000117	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—ENO1—esophageal cancer	1.44e-05	0.000116	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS1—esophageal cancer	1.44e-05	0.000116	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.44e-05	0.000116	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.43e-05	0.000116	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.43e-05	0.000116	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.42e-05	0.000115	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.42e-05	0.000115	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PSME1—esophageal cancer	1.42e-05	0.000115	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PSME2—esophageal cancer	1.42e-05	0.000115	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.41e-05	0.000114	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.41e-05	0.000114	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.37e-05	0.00011	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ENO1—esophageal cancer	1.36e-05	0.00011	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.36e-05	0.00011	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TYMP—esophageal cancer	1.35e-05	0.000109	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ENO1—esophageal cancer	1.34e-05	0.000109	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.34e-05	0.000109	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PSME2—esophageal cancer	1.34e-05	0.000108	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PSME1—esophageal cancer	1.34e-05	0.000108	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PSME1—esophageal cancer	1.32e-05	0.000107	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PSME2—esophageal cancer	1.32e-05	0.000107	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.31e-05	0.000106	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.28e-05	0.000103	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.27e-05	0.000102	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.25e-05	0.000101	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CREBBP—esophageal cancer	1.25e-05	0.000101	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.22e-05	9.88e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.22e-05	9.86e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TPI1—esophageal cancer	1.22e-05	9.86e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.18e-05	9.52e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.17e-05	9.45e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.16e-05	9.34e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.15e-05	9.31e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.15e-05	9.29e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.14e-05	9.23e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.13e-05	9.1e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.12e-05	9.01e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—NOS3—esophageal cancer	1.12e-05	9.01e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.08e-05	8.76e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.08e-05	8.69e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.07e-05	8.68e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GNG7—esophageal cancer	1.06e-05	8.57e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.06e-05	8.52e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—HMOX1—esophageal cancer	1.05e-05	8.48e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—ABCB1—esophageal cancer	1.03e-05	8.34e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—esophageal cancer	1.02e-05	8.24e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ALDH2—esophageal cancer	9.95e-06	8.03e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—HMOX1—esophageal cancer	9.89e-06	7.99e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—HMOX1—esophageal cancer	9.81e-06	7.92e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.62e-06	7.77e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—ABCB1—esophageal cancer	9.5e-06	7.67e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTT1—esophageal cancer	9.46e-06	7.64e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—ABCB1—esophageal cancer	9.41e-06	7.6e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	9.35e-06	7.55e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CREBBP—esophageal cancer	9.13e-06	7.37e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS1—esophageal cancer	8.87e-06	7.16e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ENO1—esophageal cancer	8.87e-06	7.16e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PSME2—esophageal cancer	8.74e-06	7.06e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PSME1—esophageal cancer	8.74e-06	7.06e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—EP300—esophageal cancer	8.48e-06	6.85e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—NOS3—esophageal cancer	8.18e-06	6.6e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.81e-06	6.3e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.54e-06	6.09e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—esophageal cancer	7.48e-06	6.04e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.12e-06	5.75e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	7.09e-06	5.72e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CREBBP—esophageal cancer	6.9e-06	5.57e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CREBBP—esophageal cancer	6.74e-06	5.44e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.47e-06	5.22e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CREBBP—esophageal cancer	6.35e-06	5.13e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CREBBP—esophageal cancer	6.29e-06	5.08e-05	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PIK3CA—esophageal cancer	6.28e-06	5.07e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—EP300—esophageal cancer	6.22e-06	5.02e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—ABCB1—esophageal cancer	6.21e-06	5.01e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—NOS3—esophageal cancer	6.18e-06	4.99e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—NOS3—esophageal cancer	6.03e-06	4.87e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—NOS3—esophageal cancer	5.68e-06	4.59e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.65e-06	4.56e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—NOS3—esophageal cancer	5.63e-06	4.55e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—esophageal cancer	5.52e-06	4.45e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—esophageal cancer	5.2e-06	4.2e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—esophageal cancer	5.15e-06	4.16e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—EP300—esophageal cancer	4.7e-06	3.8e-05	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PIK3CA—esophageal cancer	4.6e-06	3.72e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—EP300—esophageal cancer	4.59e-06	3.7e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—EP300—esophageal cancer	4.32e-06	3.49e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—EP300—esophageal cancer	4.29e-06	3.46e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.15e-06	3.35e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—NOS3—esophageal cancer	3.72e-06	3e-05	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.48e-06	2.81e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.4e-06	2.74e-05	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.39e-06	2.74e-05	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.2e-06	2.58e-05	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.17e-06	2.56e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—EP300—esophageal cancer	2.83e-06	2.28e-05	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.09e-06	1.69e-05	CbGpPWpGaD
